Report Update

Building on Canada’s Strengths in Regenerative Medicine: Workshop Participants

Workshop attendees participated in a two-day discussion to respond to the charge set out by Innovation, Science, and Economic Development Canada (ISED) and Health Canada. The participants had expertise, experience, and demonstrated leadership in Canadian research and development in the area of regenerative medicine; translating research into clinical practice; public awareness; supportive infrastructure such as funding and collaborative networks; and policies governing research, clinical translation, and delivery of therapies.

Anne-Marie Alarco, Chief Scientific Officer, CellCAN (Montreal, QC)

Jane Aubin, Chief Scientific Officer and Vice-President, Research, Knowledge Translation and Ethics, Canadian Institutes of Health Research (Ottawa, ON)

Paul A. Cassar, Associate Scientist, Project Research and Development, The Centre for Drug Research and Development (CDRD) (Vancouver, BC)

Tina Ceroni, Member, Board of Directors, Patient Advocate, Clinical Trials Ontario (Toronto, ON)

Sandra Donaldson, Vice President, Strategy and Partnerships, Ontario Institute for Regenerative Medicine (OIRM) (Toronto, ON)

Connie Eaves, FRSC, Distinguished Scientist, British Columbia Cancer Agency; Professor, Medical Genetics, and Associate Member of Medicine, and Pathology & Laboratory Medicine, University of British Columbia (Vancouver, BC)

Julie Fradette, Full Professor, CR CHU de Québec, Université Laval (Québec, QC)

Clive Glover, Product Leader, Cell Therapy, GE Healthcare (Cardiff, United Kingdom)

Debra Mathews, Assistant Director for Science Programs, Johns Hopkins Berman Institute of Bioethics; Associate Professor, Department of Pediatrics, Johns Hopkins University School of Medicine (Baltimore, MD)

Michael May, President & Chief Executive Officer, Centre for the Commercialization of Regenerative Medicine (CCRM) (Toronto, ON)

Christopher McCabe, PACEOMICS Project Leader; Research Director, Capital Health Endowed Chair, Department of Emergency Medicine, University of Alberta (Edmonton, AB)

Ivar Mendez, FCAHS, Fred H. Wigmore Professor and Unified Head of the Department of Surgery, University of Saskatchewan and Saskatoon Health Region (Saskatoon, SK)

Milica Radisic, FCAE, Professor, Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry, University of Toronto; Affiliated Scientist, Toronto General Research Institute (Toronto, ON)

Victor Rafuse, Professor and Director, Brain Repair Centre, Department of Medical Neuroscience, Dalhousie University (Halifax, NS)

Michael Sefton, FCAE, FRSC, University Professor and Michael E. Charles Professor of Chemical Engineering, Director and University Professor, Institute of Biomaterials and Biomedical Engineering and  University of Toronto (Toronto, ON)

Duncan Stewart, FCAHS, FRSC, CEO & Scientific Director, Ottawa Hospital Research Institute (Ottawa, ON)

Sowmya Viswanathan, Assistant Professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto; Affiliate Scientist, Arthritis Program, Krembil Research Institute, University Health Network; Cell Therapy Program, University Health Network; Manufacturing Lead, CellCAN (Toronto, ON)

Peter Zandstra, FRSC, Professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto (Toronto, ON)